Business Description
Kestra Medical Technologies Ltd
NAICS : 334516
SIC : 3841
ISIN : BMG524411052
Total Employee Number:
330Description
Kestra Medical Technologies Ltd is a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. It has developed and is commercializing its Cardiac Recovery System platform, a comprehensive and developed system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution. The cornerstone of its Cardiac Recovery System platform is the ASSURE WCD, a next-generation wearable cardioverter defibrillator (WCD) used to protect patients at an elevated risk of sudden cardiac arrest (SCA), a prominent public health problem.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 6.26 | |||||
Equity-to-Asset | 0.76 | |||||
Debt-to-Equity | 0.16 | |||||
Debt-to-EBITDA | -0.36 | |||||
Piotroski F-Score | N/A/9 | |||||
Altman Z-Score | 7.12 | |||||
Beneish M-Score | -2.75 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -38.3 | |||||
3-Year EPS without NRI Growth Rate | -47.3 | |||||
3-Year FCF Growth Rate | -40.6 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 28 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 46.85 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 28.75 | |||||
9-Day RSI | 45.99 | |||||
14-Day RSI | 51.96 | |||||
3-1 Month Momentum % | 5.62 | |||||
6-1 Month Momentum % | -6.59 | |||||
12-1 Month Momentum % | 35.13 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 7.32 | |||||
Quick Ratio | 7.16 | |||||
Cash Ratio | 6.79 | |||||
Days Inventory | 56.35 | |||||
Days Sales Outstanding | 42.18 | |||||
Days Payable | 191.27 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Shareholder Yield % | -14.87 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 48.75 | |||||
Operating Margin % | -171.53 | |||||
Net Margin % | -172.99 | |||||
EBITDA Margin % | -152.89 | |||||
FCF Margin % | -143.59 | |||||
OCF Margin % | -103.96 | |||||
ROE % | -127.59 | |||||
ROA % | -55.87 | |||||
ROIC % | -254.5 | |||||
3-Year ROIIC % | -164.39 | |||||
ROC (Joel Greenblatt) % | -312.75 | |||||
ROCE % | -61.45 | |||||
Moat Score | 3 | |||||
Tariff Resilience Score | 7 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 15.15 | |||||
PB Ratio | 4.89 | |||||
Price-to-Tangible-Book | 4.91 | |||||
EV-to-EBIT | -8.56 | |||||
EV-to-EBITDA | -9.11 | |||||
EV-to-Revenue | 13.94 | |||||
EV-to-FCF | -9.71 | |||||
| Price-to-Net-Current-Asset-Value | 6.35 | |||||
| Price-to-Net-Cash | 7.07 | |||||
Earnings Yield (Greenblatt) % | -11.68 | |||||
FCF Yield % | -8.52 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:KMTS
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Kestra Medical Technologies Ltd Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 83.721 | ||
| EPS (TTM) ($) | -3.96 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 56.34 | ||
| 14-Day RSI | 51.96 | ||
| 14-Day ATR ($) | 1.572476 | ||
| 20-Day SMA ($) | 23.97075 | ||
| 12-1 Month Momentum % | 35.13 | ||
| 52-Week Range ($) | 13.25 - 29.9999 | ||
| Shares Outstanding (Mil) | 58.37 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Kestra Medical Technologies Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Kestra Medical Technologies Ltd Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Second quarter earnings conference call for 2026 | 2026-12-11 16:30 | In 150 days | ||
| Second quarter earnings results for 2026 | 2026-12-11 | In 149 days | ||
| First quarter earnings conference call for 2027 | 2026-09-11 16:30 | In 59 days | ||
| First quarter earnings results for 2027 | 2026-09-11 | In 58 days | ||
| General meeting for 2026 | 2026-09-03 11:30 | In 51 days | ||
| Annual report for 2026 | 2026-08-14 | In 30 days | ||
| Fourth quarter earnings conference call for 2026 | 2026-07-14 16:30 | 24.76 (-3.62%) | ||
| Fourth quarter earnings results for 2026 | 2026-07-14 | 24.76 (-3.62%) | ||
| Guidance call for 2026 | 2026-05-13 14:20 | 21.57 (-1.24%) | ||
| Third quarter earnings conference call for 2026 | 2026-03-17 16:30 | 19.26 (+0.47%) |
Show
Entries
Kestra Medical Technologies Ltd Frequently Asked Questions
What is Kestra Medical Technologies Ltd(KMTS)'s stock price today?
The current price of KMTS is $24.24. The 52 week high of KMTS is $30.00 and 52 week low is $13.25.
When is next earnings date of Kestra Medical Technologies Ltd(KMTS)?
The next earnings date of Kestra Medical Technologies Ltd(KMTS) is 2026-07-14.
Does Kestra Medical Technologies Ltd(KMTS) pay dividends? If so, how much?
Kestra Medical Technologies Ltd(KMTS) does not pay dividend.
Guru Commentaries on NAS:KMTS
No articles.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Kestra Medical Technologies Ltd
Kestra Medical Technologies Ltd (KMTS) Q4 2026 Earnings Call Highlights: Record Revenue Growth and Strategic Expansion
22 minutes ago
Headlines
See More- 1
Jul 14, 2026
Kestra expects $137M FY2027 revenue while targeting 70%+ gross margins in the next few years
Seeking Alpha • 5:59pm
- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers